While more paired samples are needed to demonstrate accuracy as a leukemia surveillance tool, our ddPCR test showed sensitive changes in TAA/ABL1 ratios that matched clinical course even in low level leukemia disease over the course of treatment. This evidence concerns the gene ABL1 and leukemia.